Literature DB >> 23460142

Vacuolar-type proton pump ATPases: acidification and pathological relationships.

Ge-Hong Sun-Wada1, Yoh Wada.   

Abstract

Vacuolar H(+)(-)translocating ATPase (V-ATPase) is a universal proton pump, and its activity is required for a variety of cell biological processes, such as membrane trafficking, receptor-mediated endocytosis, lysosomal degradation of macromolecules, osteoclastic bone resorption, and the maintenance of acid-base homeostasis by renal intercalated cells. V-ATPase is targeted to various membranes and has different compositions depending on its cellular location. Here, we focus on recent knowledge concerning the targeting mechanism of V-ATPase, a process associated with a wide spectrum of diseases. We also discuss the functions of this enzyme in macrophages and cancer cells-2 characteristic cell types with clinical importance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460142     DOI: 10.14670/HH-28.805

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  21 in total

1.  Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4.

Authors:  Sally Esmail; Norbert Kartner; Yeqi Yao; Joo Wan Kim; Reinhart A F Reithmeier; Morris F Manolson
Journal:  J Biol Chem       Date:  2018-01-08       Impact factor: 5.157

2.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles.

Authors:  Jingwei Ma; Yi Zhang; Ke Tang; Huafeng Zhang; Xiaonan Yin; Yong Li; Pingwei Xu; Yanling Sun; Ruihua Ma; Tiantian Ji; Junwei Chen; Shuang Zhang; Tianzhen Zhang; Shunqun Luo; Yang Jin; Xiuli Luo; Chengyin Li; Hongwei Gong; Zhixiong Long; Jinzhi Lu; Zhuowei Hu; Xuetao Cao; Ning Wang; Xiangliang Yang; Bo Huang
Journal:  Cell Res       Date:  2016-05-10       Impact factor: 25.617

Review 3.  Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness.

Authors:  Christina McGuire; Kristina Cotter; Laura Stransky; Michael Forgac
Journal:  Biochim Biophys Acta       Date:  2016-02-22

4.  Glucose starvation increases V-ATPase assembly and activity in mammalian cells through AMP kinase and phosphatidylinositide 3-kinase/Akt signaling.

Authors:  Christina M McGuire; Michael Forgac
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

5.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.

Authors:  F Lozupone; M Borghi; F Marzoli; T Azzarito; P Matarrese; E Iessi; G Venturi; S Meschini; A Canitano; R Bona; A Cara; S Fais
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

7.  Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Authors:  Verena Paulitschke; Ossia Eichhoff; Christopher Gerner; Philipp Paulitschke; Andrea Bileck; Thomas Mohr; Phil F Cheng; Alexander Leitner; Emmanuella Guenova; Ieva Saulite; Sandra N Freiberger; Anja Irmisch; Bernhard Knapp; Nina Zila; Theodora-Pagona Chatziisaak; Jürgen Stephan; Joanna Mangana; Rainer Kunstfeld; Hubert Pehamberger; Ruedi Aebersold; Reinhard Dummer; Mitchell P Levesque
Journal:  EMBO J       Date:  2019-06-26       Impact factor: 11.598

Review 8.  Recent Insights into the Structure, Regulation, and Function of the V-ATPases.

Authors:  Kristina Cotter; Laura Stransky; Christina McGuire; Michael Forgac
Journal:  Trends Biochem Sci       Date:  2015-10       Impact factor: 13.807

Review 9.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

10.  Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression.

Authors:  Xiaodong Lu; Lufang Chen; Yuanyuan Chen; Qixiang Shao; Wenxin Qin
Journal:  Exp Ther Med       Date:  2015-09-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.